S6E8: 6. The clinical trial process in new drug development

<p><a href='https://www.crinetics.com/alan-s-krasner-m-d/'>Dr. Alan Krasner,</a> Chief Medical Officer, and Dr. Chris Cook, Medical Director, Endocrinology at <a href='https://www.crinetics.com'>Crinetics Pharmaceuticals</a> offer an in-depth look at clinical studies.  In this podcast, we cover a <a href='https://www.crinetics.com/pipeline/oral-sst2-selective-agonists/'>promising molecule - CRNOO808</a> - under development for acromegaly and neuroendocrine tumors (NET's), and another hopeful new drug for <a href='https://www.chop.edu/conditions-diseases/congenital-hyperinsulinism'>pediatric congenital hyperinsulinism</a>.  They talked about the challenges, their hopes for new therapeutic strategies, the complexities of their work, and how patients can get involved with industry and government regulators to improve these drugs and therapies.   <a href='https://www.pituitaryworldnews.org/category/podcasts/'>Click here</a> to listen to more podcasts.</p>